There’s a hell of a lot to like about GlaxoSmithKline (LSE: GSK) from an investment point of view. It’s always been committed to paying juicy, inflation-busting dividends, even when patent expirations …

More Forget GlaxoSmithKline! 2 ‘better’ pharmaceutical stocks I think could help you retire in luxury Videos